Company Filing History:
Years Active: 2004-2010
Title: Innovations and Contributions of Jennifer Leigh Rohn
Introduction
Jennifer Leigh Rohn is a prominent inventor based in Amsterdam, Netherlands. She has made significant contributions to the field of apoptosis, particularly in developing novel therapeutic approaches for cancer treatment. With a total of five patents to her name, her work has the potential to impact cancer diagnostics and therapies significantly.
Latest Patents
One of her latest patents focuses on Apoptin-associating proteins. This invention provides novel therapies, including combinatorial therapies and therapeutic compounds that can work alone or in conjunction with Apoptin. It is particularly relevant in cases where the p53 protein is non-functional. Another significant patent involves modifications of Apoptin, specifically phosphorylated Apoptin, which is tumor-specifically phosphorylated. This research elucidates the Apoptin apoptotic pathway in tumor cells and opens up new therapeutic possibilities. The invention also describes diagnostic methods for detecting cancer cells and identifying potential cancer-inducing agents.
Career Highlights
Jennifer Rohn is associated with Leadd B.V., where she continues her innovative research. Her work has garnered attention in the scientific community, and she is recognized for her contributions to cancer research and therapy development.
Collaborations
Some of her notable coworkers include Mathieu Hubertus M Noteborn and Astrid Adriana A M Danen-van Oorschot. Their collaborative efforts enhance the research environment and contribute to the advancement of cancer therapies.
Conclusion
Jennifer Leigh Rohn's innovative work in the field of apoptosis and cancer therapy showcases her dedication to improving medical outcomes. Her patents reflect a commitment to advancing scientific knowledge and developing effective treatments for cancer.